Suchergebnisse - "Teixeira, Julio"

PubPharm (11)

1

Cervical cancer screening program based on primary DNA-HPV testing in a Brazilian city : a cost-effectiveness study protocol

enthalten in: BMC public health | 2020

von Teixeira, J. | Vale, D. | Bragança, J. | +3

2

Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women : results from the control arm of a phase II HPV-16/18 vaccine trial

enthalten in: BMJ open | 2016

von Ramanakumar, A. | Naud, P. | Roteli-Martins, C. | +13

ErratumIn: BMJ Open. 2016 Sep 02;6(9):e011371corr1. - PMID 27591019

3

MMP-9/RECK Imbalance : A Mechanism Associated with High-Grade Cervical Lesions and Genital Infection by Human Papillomavirus and Chlamydia trachomatis

enthalten in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology | 2015

von Discacciati, M. | Gimenes, F. | Pennacchi, P. | +12

4

Efficacy of human papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women : final event-driven analysis of the randomized, double-blind PATRICIA trial

enthalten in: Clinical and vaccine immunology : CVI | 2015

von Apter, D. | Wheeler, C. | Paavonen, J. | +125

5

Post hoc analysis of the PATRICIA randomized trial of the efficacy of human papillomavirus type 16 (HPV-16)/HPV-18 AS04-adjuvanted vaccine against incident and persistent infection with nonvaccine oncogenic HPV types using an alternative multiplex type-specific PCR assay for HPV DNA

enthalten in: Clinical and vaccine immunology : CVI | 2015

von Struyf, F. | Colau, B. | Wheeler, C. | +28

6

Development of a Multiplex PCR Test with Automated Genotyping Targeting E7 for Detection of Six High-Risk Human Papillomaviruses

enthalten in: PloS one | 2015

von Paes, E. | de Assis, A. | Teixeira, C. | +2

7

Risk of newly detected infections and cervical abnormalities in women seropositive for naturally acquired human papillomavirus type 16/18 antibodies : analysis of the control arm of PATRICIA

enthalten in: The Journal of infectious diseases | 2014

von Castellsagué, X. | Naud, P. | Chow, S. | +28

CommentIn: J Infect Dis. 2014 Aug 15;210(4):507-9. - PMID 24610878

8

Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine : final analysis of a long-term follow-up study up to 9.4 years post-vaccination

enthalten in: Human vaccines & immunotherapeutics | 2014

von Naud, P. | Roteli-Martins, C. | De Carvalho, N. | +7

9

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types : 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

enthalten in: The Lancet. Oncology | 2012

von Wheeler, C. | Castellsagué, X. | Garland, S. | +125

ErratumIn: Lancet Oncol. 2012 Jan;13(1):e1

10

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia : 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

enthalten in: The Lancet. Oncology | 2012

von Lehtinen, M. | Paavonen, J. | Wheeler, C. | +128

ErratumIn: Lancet Oncol. 2012 Jan;13(1):e1